Orin
ROLNYSE·Personal Products & Services

Rollins, Inc.

Market cap $16.4BP/E 31.2× trailingGross margin 51.3%Reports Wed 10 Feb 2027, after the close
$34.01
−0.54 (−1.56%)Tue 27 Oct close 16:00 ET
52-wk $29.29 – $66.14
Orin's take
6out of 10 — how sure Orin is of this read

Orin's own judgment of how firmly the evidence points one way — not the chance the price goes up.

Refreshed 20 Oct, the 9th take on ROL — written before the latest earnings report. An update has been queued since 21 Oct and hasn't run yet.

Rollins remains a high-quality compounder — FY2025 revenue of $3.76B grew 11% with a 19.3% operating margin and $650M free cash flow on just $28M capex — but the stock sits in a no-man's land after de-rating from its 200-day MA of $48.08 to $32.66, with RSI now neutral at 50.1 rather than oversold.

Revenue growth has decelerated from 12.0% in Q3 2025 to 7.9% in Q2 2026, and Q3 2026 is expected to show roughly flat EPS amid buyout and integration costs per Zacks. While ROL trades at a 25% P/E discount to the peer median of 39.75x, the combination of decelerating top-line growth, recent EPS misses, and unresolved AI-driven lead-generation disruption keeps the risk/reward balanced rather than compelling ahead of the imminent Q3 print.

What could go wrong

  • Revenue growth deceleration. Q2 2026 YoY revenue growth slowed to 7.9% from 12.1% in Q2 2025 and 12.0% in Q3 2025; if this trend persists it undermines the premium-growth thesis.
  • AI search disruption to lead generation. Per recent Seeking Alpha coverage, AI-driven search changes are disrupting residential marketing funnels, a key customer acquisition channel for the 75% recurring-revenue business.
  • Insider selling overhang. Over 24 months, insiders net disposed 59.5M shares worth $3.39B, dominated by Rollins family trust transactions (code J); post-lockup family share sales remain a cited risk.
  • Rising leverage. Total debt rose from $812.5M in FY2024 to $1.04B in FY2025, increasing interest expense sensitivity if integration costs continue to pressure margins.

What would change my mind

Q3 2026 earnings reacceleration. Q3 2026 revenue growth exceeds 10% YoY and EPS beats consensus, signaling integration costs are transitorybullish
Sustained growth below 8%. Q3 and Q4 2026 revenue growth remains below 8% with further EPS misses, confirming structural decelerationbearish
Margin stabilization. Gross margin holds at or above 52.7% (FY2025 level) for two consecutive quarters, indicating pricing power is intact despite acquisition costsbullish
Significant insider buying. Non-grant insider open-market purchases emerge, reversing the 24-month net disposition trendbullish

Where this comes from: FY25 fundamentals · quarterly results · technicals, 19 Oct · peer comparison. Orin's read on ROL; not advice.

How has the share price moved?

27 Oct 2025 – 27 Oct 2026

Down 39.5% over twelve months, from $56.23 on 27 Oct 2025 to $34.01 at the Tue 27 Oct 2026 close. Its highest close in that time was $65.60 on 11 Feb 2026; the last close is 48.2% below it.

Jan 2026AprJulOct
    • Green line: the closing price each trading day.
    • Grey line: the average closing price over the last 50 trading days.
    • Dashed amber line: the same over the last 200 trading days — a slower, smoother line.
    • Bars along the bottom: shares traded each day — green when it closed higher than the day before, rose when lower (the most, 18.0M, on 23 Jul 2026).
    • Flags: the company's filings, on the day they were made (a 10-Q is the quarterly report and a 10-K the annual report; an 8-K reports a major event).

    Largest holders · 13F Q2 2026

    Money flow
    FilerPositionOf fund
    BlackRock$1.2B0.0%
    Vanguard Capital Management$826.4M0.0%
    Vanguard Portfolio Management$708.6M0.0%
    State Street$566.0M0.0%
    Geode Capital Management$490.4M0.0%
    Morgan Stanley$269.5M0.0%
    Invesco$255.7M0.0%
    Select Equity Group$178.8M0.9%
    Norges Bank$164.2M0.0%
    Goldman Sachs Group$125.0M0.0%

    87 of the 815 filers we track · quarter ended Q2 2026 · positions, not flows

    Insiders, last 24 months: 98 Form 4 filings; open-market trades net −$3.4B. Of the 50 on hand, 0 were open-market purchases and 1 a sale — the rest are grants, option exercises and tax withholding.

    Ask Orin about ROL

    its filings · its transcripts · its numbers

    Orin answers questions about ROL from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

    Start 3 free days →

    How is it priced, against its own past and its sector?

    Tue 27 Oct close

    Priced at 31.2× its last 12 months of profit (Tue 27 Oct close) — lower than in all 5 of its last 5 fiscal years (middle 48.7×); the typical Consumer Cyclical company on the NYSE is at 20.4×.

    MeasureNowIts usualSector
    P/E31.2×below usual48.7×20.4×
    P/S4.10×below usual6.94×—
    EV/EBITDA20.2×below usual31.1×—
    P/B11.7×below usual16.9×—
    • "Its usual" is the middle of its own last 5 fiscal years.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    P/S: the company's total market value divided by one year of revenue. Used when there is no profit to measure.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    P/B: the share price divided by the book value per share — what the company owns minus what it owes, as its accounts record it. When book value is tiny, P/B swings wildly and says little.

    What do the analysts who cover it publish?

    14 firms rated it in the last 18 months · 27 Oct

    The analysts' average 12-month price target is $39.10 (from $27 to $65) — 15% above the Tue 27 Oct close price. That is their published opinion, not Orin's.

    Average price target

    $39.10

    $27 – $65 · +15% against the last close

    Their ratings
    • 3 buy or overweight
    • 9 hold
    • 2 underweight or sell

    Price target: the share price an analyst publishes for about 12 months ahead. It is the opinion of the firm that wrote it; the average is across the firms that cover the company.

    Overweight / underweight: analysts' rating words: overweight means the firm expects the stock to do better than the others it covers, underweight worse. Their words, not Orin's.

    How is it priced next to the companies it is compared to?

    2 of 2 with a profit

    Priced at 31.2× its last 12 months of profit. Only 2 of the 2 companies it is compared to made a profit (CTAS 41.9×, ECL 39.3×), so there is no typical P/E.

    CompanyMarket valueP/EEV/EBITDAGross marginNet marginROE
    ROLRollins, Inc.$16B31.2×20.2×51.3%13.2%38%
    CTASCintas Corporation$85B41.9×27.3×51.0%17.8%42%
    ECLEcolab Inc.$82B39.3×26.1×32.0%12.0%21%
    • The list of companies is the data vendor's choice, so it can include a company a person would not have picked.

    Market value: the share price times the number of shares — what the whole company is priced at.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    Gross margin: the share of each $1 of sales left after the direct cost of making what was sold.

    Net margin: the share of each $1 of sales kept as profit after every cost. Below zero, the company lost money.

    ROE: return on equity: one year of profit as a share of the shareholders' money in the business (its book value).

    Is it priced high or low compared with its own past?

    Tue 27 Oct

    Priced at 31.2× its last 12 months of profit (Tue 27 Oct close). It has no full fiscal year on file since its history starts, so there is nothing of its own to compare with.

    • Now31.2×

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    Fiscal year (FY): the company's own 12-month accounting year, which need not match the calendar year.

    How has its sector been priced?

    Now–Now · Tue 27 Oct

    Consumer Cyclical companies on the NYSE were priced at a typical 20.4× their yearly profit (Tue 27 Oct close).

    • Now20.4×
    • Each year is the middle of that calendar year's daily sector P/E; "Now" is the Tue 27 Oct close figure, the same one in the table above.

    Sector P/E: the middle P/E of the companies in the same sector on the same stock exchange, as the data vendor works it out each day.

    What does a cash-flow model say a share is worth?

    computed 27 Oct at $33.85

    A standard cash-flow model puts it at $40 a share — 19% above the $33.85 price it was computed against (27 Oct).

    ModelValue a shareAgainst the price then
    Standard$4019% above $33.85
    Levered$4738% above $33.85

    Discounted cash flow: a model's estimate of what the company is worth today, from the cash it is forecast to make in future years. Small changes in the forecast move it a lot, and it says little about a company that loses money.

    Standard / levered: two versions of the cash-flow model: the standard one counts the cash before the company pays its lenders, the levered one after.